ArticleCureus2025
Alpha-Thalassemia Unmasked in a Patient With Sickle Cell Trait: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell trait is usually an asymptomatic, benign carrier state with mild or no anemia. We present the case of a 59-year-old female with sickle cell trait and mild persistent microcytic anemia. Iron studies were normal, and ferritin was elevated. Peripheral smear demonstrated microcytosis and occasional sickled cells. Given the marked microcytosis, molecular analysis was performed and confirmed homozygous alpha-thalassemia via gap-polymerase chain reaction. The coexistence of sickle cell trait and homozygous alpha-thalassemia accounted for the hematologic findings. Recognition of this genotype is critical to prevent misdiagnosis, avoid unnecessary iron supplementation, and guide appropriate genetic counseling and follow-up. Co-inheritance of hemoglobinopathies may present diagnostic challenges and require further investigation, particularly when laboratory results are inconsistent with expected phenotypes. In cases of unexplained microcytosis, especially in individuals with known hemoglobin variants, molecular testing for alpha-thalassemia should be considered to ensure accurate diagnosis and tailored management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.